Mitochondrial Diseases and Cytopathies

Mitochondrial diseases are disorders of cellular energy metabolism caused by defects in the mitochondrial respiratory chain and oxidative phosphorylation. Because mitochondria are encoded by both nuclear and mitochondrial DNA and are present in nearly every tissue, these disorders are genetically heterogeneous and clinically multisystem, with a predilection for energy-demanding tissues such as brain, muscle, heart, and the endocrine system.

Definition

A mitochondrial disease is a disorder, of nuclear or mitochondrial genetic origin, in which defective respiratory-chain and oxidative-phosphorylation function impairs cellular ATP production, typically producing multisystem disease that preferentially affects energy-dependent tissues.

Scope

The entry covers the dual-genome basis of mitochondrial function, the concept of impaired oxidative phosphorylation, key genetic principles such as heteroplasmy and maternal inheritance of mitochondrial DNA, and the multisystem clinical patterns and named syndromes that result. It is a reference overview of the disease family and does not provide management guidance for any specific syndrome.

Key concepts

• Oxidative phosphorylation and the respiratory chain
• Dual nuclear and mitochondrial DNA control
• Heteroplasmy and the threshold effect
• Maternal inheritance of mitochondrial DNA
• Multisystem involvement of energy-demanding tissues
• Lactic acidosis as a biochemical marker
• Named syndromes (MELAS, MERRF, Leigh syndrome, Kearns-Sayre)

Mechanisms

Mitochondria generate most cellular ATP through oxidative phosphorylation, in which the electron-transport chain establishes a proton gradient that ATP synthase uses to phosphorylate ADP. The complexes of this chain are assembled from subunits encoded by both the mitochondrial and the nuclear genome, so disease can arise from defects in either. A distinctive feature of mitochondrial DNA disease is heteroplasmy: a cell carries a mixture of normal and mutant mitochondrial genomes, and disease appears only when the mutant load exceeds a tissue-specific threshold, which helps explain the variable and multisystem presentation. Mitochondrial DNA is maternally inherited, giving a recognisable pedigree pattern distinct from Mendelian nuclear-gene disorders. Impaired energy production and secondary lactic acidosis underlie the clinical syndromes, as reviewed by DiMauro and Schon and by Gorman and colleagues.

Clinical relevance

Mitochondrial diseases explain why a single biochemical lesion - failure of energy production - can produce seemingly unrelated symptoms across many organs, and why inheritance can follow either maternal or Mendelian patterns. Recognising these principles clarifies the logic of diagnostic evaluation and genetic counselling. This entry summarises the conceptual and evidentiary landscape and is not a basis for individual diagnosis or treatment.

Epidemiology

Mitochondrial diseases are among the more common inherited metabolic disorders when considered as a group, with population surveys indicating that a substantial minority of adults carry pathogenic mitochondrial DNA variants, though clinical penetrance varies widely. Gorman and colleagues summarise prevalence and the genetic spectrum.

History

The link between mitochondria and human disease was established in the 1960s with descriptions of patients whose muscle showed abnormal mitochondria and loosely coupled oxidative phosphorylation. Mapping of the human mitochondrial genome and the recognition of maternal inheritance and heteroplasmy in the late twentieth century transformed the field, allowing named syndromes such as MELAS and MERRF to be tied to specific mitochondrial DNA variants. Subsequent work, reviewed by Craven and colleagues, extended the genetic catalogue to many nuclear genes affecting mitochondrial maintenance and assembly.

Key figures

• Salvatore DiMauro
• Eric Schon
• Douglass Turnbull
• Patrick Chinnery
• Anu Suomalainen

Seminal works

• dimauro-schon-2003
• gorman-2016
• craven-2017

Frequently asked questions

Why do mitochondrial diseases affect so many different organs?

Mitochondria supply energy to nearly every cell, so a defect in energy production tends to harm the most energy-demanding tissues - brain, muscle, heart, and endocrine organs - producing a multisystem pattern rather than a single-organ disease.

What is heteroplasmy and why does it matter?

Heteroplasmy means a cell contains a mixture of normal and mutated mitochondrial DNA. Disease usually appears only when the mutant proportion exceeds a tissue-specific threshold, which helps explain why severity and the organs affected vary so much between individuals.